Comparison of Hydrophilic and Lipophilic Surfactants for the Improvement of Solubility of BCS Class II Drug by First Generation Solid Dispersion Method

被引:0
|
作者
Pandey, Kapil [1 ]
Hanif, Muhammad [1 ]
Ameer, Nabeela [1 ]
Mahmood, Khalid [2 ]
Abid, Usman [1 ]
Rana, Hafsa Latif [1 ]
Batool, Fakhra [1 ,3 ]
Abbas, Ghulam [4 ]
Saadullah, Malik [4 ]
Rasool, Sumera [5 ]
机构
[1] Bahauddin Zakariya Univ Multan, Fac Pharm, Dept Pharmaceut, Multan, Pakistan
[2] Bahauddin Zakariya Univ Multan, Inst Chem Sci, Multan, Pakistan
[3] Sardar Bahadur Khan Woman Univ Quetta, Dept Pharm, Quetta, Pakistan
[4] Govt Coll Univ Faisalabad, Fac Pharmaceut Sci, Dept Pharmaceut, Faisalabad, Pakistan
[5] Bahauddin Zakariya Univ Multan, Inst Biotechnol, Multan, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2022年 / 41卷 / 03期
关键词
diclofenac sodium; Gibb's energy; polyethylene glycol; solid dispersion; solubility; surfactant's molecular weight;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Limitation of BCS class-II drugs like diclofenac sodium (DS) can be overcome by using solid dispersion technique. The purpose of the study was to calculate the effect of molecular weight of different surfactants on solubility and dissolution behavior of DS. For this purpose, two different types of surfactants i.e., lipophilic (propylene glycol and span 60) and hydrophilic (polyvinyl pyrrolidone and polyethylene glycol) were used. Solidly dispersed diclofenac sodium was prepared by simple mixing of different ratios of surfactant. Pure DS and their 1:5 SD-DS were further analyzed by phase solubility studies, FTIR analysis, while Gibbs free energy was calculated for the confirmation of electrostatic attraction between the surfactant and DS. Solubility of DS was increased from 12 to 85%, 8 to 53%, 12 to 78% and, 16 to 111% by using PVP, Span 60, PEG and PG, respectively, showing direct relation of molecular weight of surfactant with solubility. Dissolution studies showed DS-span 60-5 and DS-PG-5 follow zero order kinetics with 0.456 and 0.953 rate constants and lowest AIC value of 21.80 and 29.35%, respectively, while DS-PVP-5 and DS-PEG-5 follow Hixon-Crowell model. FTIR peaks confirmed that all spectra of DS were equivalent to spectra obtained by the addition of surfactant with peaks at 3260-3265 cm(-1), 1640- 1660 cm(-1), 1400-1600 cm(-1) and 700-800 cm(-1). Stability studies calculations confirmed the stability of DS-PG-5 with 14-month shelf life. Prepared solidly dispersed DS can be used as an alternative to less soluble DS in the treatment of osteoarthritis and various inflammatory conditions.
引用
收藏
页码:644 / 651
页数:8
相关论文
共 10 条
  • [1] Formulation Development and Assessment of Solid Dispersion and Hydrotropy for BCS Class II Drug Solubility Enhancement
    Bajwa, Neha
    Singh, Mela
    Naryal, Srishti
    Mahal, Shipra
    Mehta, Sumit
    Madan, Jitender
    Baldi, Ashish
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (02) : 305 - 319
  • [2] Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole
    Madgulkar, Ashwini
    Bandivadekar, Mithun
    Shid, Tanaji
    Rao, Shivani
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (01) : 28 - 38
  • [3] Solubility Enhancement of BCS Classified II/IV Drug - Solid Dispersion of Apixaban by Solvent Evaporation
    Asati, Amit Vinayak
    Salunkhe, Kishor Sahebrao
    Chavan, Machindra Jairam
    Chintamani, Ravindra Bhausaheb
    Singh, Rudra Pratap
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2020, 10 (04) : 430 - 436
  • [4] Enhanced Aqueous Solubility of the Solid Forms of a BCS Class-II Anti-Tuberculosis Drug, Prothionamide
    Amrutha, S.
    Giri, Lopamudra
    SeethaLekshmi, Sunil
    Varughese, Sunil
    CRYSTAL GROWTH & DESIGN, 2020, 20 (08) : 5086 - 5096
  • [5] Enhancement of Solubility and Dissolution Rate of BCS Class-II Fluvoxamine Tablets using Solvent Evaporation Solid Dispersion Technique
    Srinivas, Martha
    Singh, Anoop
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (31B) : 44 - 53
  • [6] Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying
    Fong, Sophia Yui Kau
    Ibisogly, Asiye
    Bauer-Brandl, Annette
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 496 (02) : 382 - 391
  • [7] Development and Characterization of Fast-Dissolving Tablets to Enhance Bioavailability of BCS Class II Drugs by Solid Dispersion Method
    Sathish, S. K.
    Janakiraman, K.
    Muthumani, M.
    CURRENT PHARMACEUTICAL ANALYSIS, 2024,
  • [8] Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants and Crystallization Inhibitors: Development of Controlled-Release Tablets
    Emad B. Basalious
    Wessam El-Sebaie
    Omaima El-Gazayerly
    AAPS PharmSciTech, 2011, 12 : 799 - 810
  • [9] Application of Pharmaceutical QbD for Enhancement of the Solubility and Dissolution of a Class II BCS Drug using Polymeric Surfactants and Crystallization Inhibitors: Development of Controlled-Release Tablets
    Basalious, Emad B.
    El-Sebaie, Wessam
    El-Gazayerly, Omaima
    AAPS PHARMSCITECH, 2011, 12 (03): : 799 - 810
  • [10] Effects of Ingested Water Volume on Oral Absorption of Fenofibrate, a BCS Class II Drug, from Micronized and Amorphous Solid Dispersion Formulations in Rats
    kataoka, Makoto
    Ikkou, Sakiho
    Kato, Yuki
    Minami, Keiko
    Higashino, Haruki
    Takagi, Toshihide
    Yamashita, Shinji
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (10) : 1452 - 1457